Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of 36% to 50% Research Summary
https://jamanetwork.com/journals/jama/fullarticle/2853394
This trial tested whether implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death (SCD) or hemodynamically significant ventricular arrhythmia (HSVA) in patients with a left ventricular ejection fraction (LVEF) of 36% to 50% and myocardial scar.
August 29, 2026 473
